Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial.
Dunn JA, Donnelly P, Elbeltagi N, Marshall A, Hopkins A, Thompson AM, Audisio R, Pinder SE, Cameron DA, Hartup S, Turner L, Young A, Higgins H, Watson EK, Gasson S, Barrett-Lee PJ, Hulme C, Shinkins B, Hall PS, Evans A.
Dunn JA, et al. Among authors: hall ps.
Lancet. 2025 Feb 1;405(10476):396-407. doi: 10.1016/S0140-6736(24)02715-6.
Lancet. 2025.
PMID: 39892911
Clinical Trial.